Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04380974 Not yet recruiting - Clinical trials for Polypoidal Choroidal Vasculopathy

Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy

Start date: June 2020
Phase: Phase 4
Study type: Interventional

The study will evaluate the efficacy and safety of two different regimens of anti-VEGF Therapy (OCTA plus OCT guided 3+PRN vs. OCT guided 3+PRN) in Chinese patients with PCV. This study is to provide long-term safety data in the treatment of Chinese patients with PCV.

NCT ID: NCT04379180 Not yet recruiting - Clinical trials for Persistent Pulmonary Hypertension of the Newborn

Population Pharmacokinetics and Dosage Individualization of Oral Pulmonary Vasodilators in PPHN

Start date: April 26, 2020
Phase:
Study type: Observational

The use of bosentan, sildenafil and tadalafil in neonates with persistent pulmonary hypertension (PPHN) depends mostly on the empirical experience of pediatricians. Moreover, the recommended dose of those three drugs in treating PPHN remains controversial. Therefore, our aim is to study the pharmacokinetics and pharmacodynamics of bosentan, sildenafil and tadalafil in neonates of PPHN then dose a tailor-made therapeutic regimen.

NCT ID: NCT04375059 Not yet recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

Effects of Attention Training on Children

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

Using a double-blind, randomized controlled design to investigate the therapeutic effects of interactive attention training for children with Attention Deficit Hyperactivity Disorder who are receiving conventional rehabilitation programs due to developmental delay.

NCT ID: NCT04372784 Not yet recruiting - Clinical trials for Esophageal Stricture

Cryoablation for Benign Gastrointestinal Anastomotic Strictures

Start date: September 2020
Phase: N/A
Study type: Interventional

Anastomotic stricture is a common complication following foregut surgery. The standard of care for these benign foregut anastomotic strictures is balloon dilatation. However, re-stenosis of strictures is also common, requiring frequent repetition of balloon dilatation. Cryotherapy is a novel therapy that may improve clinical outcomes following dilatation. The purpose of the present study is to conduct a randomized controlled trial to characterize the impact of cryotherapy on clinical outcomes and complications for benign anastomotic strictures following esophagectomy, gastrectomy, and bariatric surgery.

NCT ID: NCT04367272 Not yet recruiting - Clinical trials for Osteoarthritis, Knee

Is Second Knee at Risk During Simultaneous Bilateral Total Knee Arthroplasty.

Start date: May 15, 2020
Phase: N/A
Study type: Interventional

The effects of single-team simultaneous bilateral total knee arthroplasty on peri- and postoperative complications are clear. The investigators hypothesized that second knee at risk during single-team simultaneous bilateral total knee arthroplasty and have more early postoperative complication rates than the first knee. Therefore, this prospective study compared minor and major local complications for 90 days postoperatively between the first and second during knee single-team simultaneous bilateral total knee arthroplasty.

NCT ID: NCT04364932 Not yet recruiting - Clinical trials for Neonatal Hypoxic Ischemic Encephalopathy

Antenatal and Intrapartum Risk Factors Associated With Neonatal Hypoxic Ischemic Encephalopathy

Start date: September 2021
Phase:
Study type: Observational

Perinatal asphyxia is a major cause of hypoxic Ischemic encephalopathy (HIE), perinatal death and long term neurodisability. This can be devastating for the individual and their family; the healthcare and litigation costs notwithstanding. In recent years have attempted to quantify the effect, and wider impact of intrapartum compromise, as well as the underlying mechanisms for it. After a poor outcome related to intrapartum care parents and healthcare practitioners often strive to understand whether the event could have been predicted and/or prevented. This can be difficult to answer, at least partly related to the heterogeneous fetal response to perinatal asphyxia. Mothers and the maternity service are increasingly encouraged to personalize care and their choices around the birth process, however the information required to guide these choices is most often missing. This makes it difficult for women and professionals to make an informed choice about their care, including the safest mode of birth for them and their baby. Aim of the study: Identifying antenatal and intrapartum risk factors associated with neonatal hypoxic ischemic encephalopathy.

NCT ID: NCT04362787 Not yet recruiting - Clinical trials for Acute Hypercapnic Respiratory Failure

High Pressure Non Invasive Ventilation in Hypercapnic Respiratory Failure

Start date: August 1, 2020
Phase:
Study type: Observational

High pressure NIV is a pressure limited ventilation, stating IPAP pressure at 20 cmH2O and gradually increasing pressure up to 30 cmH2O according to patient tolerance.

NCT ID: NCT04362020 Not yet recruiting - Clinical trials for Patient Undergoing Diagnostic Coronary Angiography

Strategies to Maintain Radial Artery Patency Following Diagnostic Coronary Angiography - Subgroup of Patients on Oral Anticoagulants

RAPID-2
Start date: May 1, 2020
Phase: N/A
Study type: Interventional

To investigate whether omitting systemic anticoagulation during transradial coronary angiography and/or a distal radial access reduce the risk of postprocedural radial artery occlusion

NCT ID: NCT04361903 Not yet recruiting - Clinical trials for Severe Acute Respiratory Syndrome Coronavirus 2

Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection

RESPIRE
Start date: April 25, 2020
Phase:
Study type: Observational

It is an observational, cohort, retrospective, monocentric, non-profit study. The primary objective is to evaluate the efficacy and safety of ruxolitinib in acute respiratory distress syndrome in patients with SARS-CoV-2 COVID-19 with rapid deterioration of respiratory parameters in the last 12 hours.

NCT ID: NCT04361812 Not yet recruiting - Clinical trials for Similarity of Pharmacokinetics and Safety

Comparison of Pharmacokinetics and Safety of HS632 and Xolair® With a Single Injection

Start date: October 15, 2020
Phase: Phase 1
Study type: Interventional

To evaluate the bioequivalence of HS632 and Omalizumab (Xolair®) in a single subcutaneous administration in healthy subjects.